Kays Financial Advisory’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,345
Closed -$1.98M 109
2019
Q4
$1.98M Buy
10,345
+369
+4% +$66.6K 0.35% 42
2019
Q3
$1.68M Sell
9,976
-147
-1% -$23.9K 0.31% 46
2019
Q2
$1.7M Buy
10,123
+303
+3% +$42K 0.31% 44
2019
Q1
$1.44M Buy
+9,820
New +$1.42M 0.28% 50

Other funds holding AGN

Kays Financial Advisory's AGN Position: Q1 2020 in Review

Kays Financial Advisory sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 10,345 shares — an estimated $1.98M sold.

Kays Financial Advisory first reported a position in AGN in Q1 2019 and held it in 4 quarters. The position peaked at $1.98M in Q4 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Kays Financial Advisory reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Kays Financial Advisory sold 10,345 Allergan plc shares in Q1 2020, an estimated $1.98M.
  • Kays Financial Advisory first reported a position in Allergan plc in Q1 2019 and held it in 4 quarters.
  • Kays Financial Advisory's Allergan plc position peaked at $1.98M in Q4 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Kays Financial Advisory's 13F filing for Q1 2020, filed 7 May 2020.